TOP

COVID-19 New Products, Anti-SARS-CoV-2 Fully Human RBD IgG Quality Controls

Date: 2020-06-12
Views: 455

The rapid launch of Fapon COVID-19 S & N Recombinant Proteins for Immunoassay in February has been received positive feedback from customers with the demonstration of excellent performance in applications.

 

To continuously expand the COVID-19 product line, Fapon is officially launching the Anti-SARS-CoV-2 Fully Human RBD IgG Quality Control. Another product, the Anti-SARS-CoV-2 Fully Human RBD IgM Quality Control, will be introduced soon to join the collection.



Fapon Anti-SARS-CoV-2 Fully Human RBD IgG Quality Control


Fapon Anti-SARS-CoV-2 Fully Human RBD IgG Recombinant Antibody is produced by natural human infection with HIGH SENSITIVITY IN PERFORMANCE. By isolating PBMC (Peripheral Blood Mononuclear Cell) from the blood of SARS-CoV-2 recovered patients, cells that have positive reactions to RBD antigens are selected to obtain IgG recombinant antibodies through gene recombination and cloning.

 

The reactivity of Fapon IgG recombinant antibody to RBD is more consistent with the reactivity of the serum of SARS-CoV-2 patients, which OUTPERFORMS OTHER HUMANIZED ANTIBODIES OBTAINED BY IMMUNIZED MICE WITH RECOMBINANT ANTIGENS in the market as their consistency to infected serum are relatively lower. After validation by different parties, Fapon IgG quality control is proved to be stable and can be applied in COVID-19 IgG antibody detection.



Product Performance


ELISA Platform —— Indirect ELISA Method


Catalog No.

FPZ0537/FPZ0555 (Coating) + BEEIGGI102 (Conjugate)

+ FPZ0569 (Quality Control)


COVID-19 New Products, Anti-SARS-CoV-2 Fully Human RBD IgG Quality Controls


Colloidal Gold Platform——Antibody Capture Method 


Catalog No.

FPZ0555 (Coating) + BENIGGI107/BRCIGGS101 (Conjugate)

+ FPZ0569 (Quality Control)

Concentration of FPZ0569

(μg/ml)

1

0.5

0.25

0.125

0.0625

0.03125

0.0156

Color Intensity

C1

C2

C3

C5

C6

C7

C9


Colloidal Gold Platform——Indirect Method 


Catalog No.

BRCIGGS101 (Coating) + FPZ0537 (Conjugate) + FPZ0568 (Quality Control)

Concentration of FPZ0568

(μg/ml)

1

0.5

0.25

0.125

0.0625

0.03125

0.0156

0.0078

Color Intensity

C1

+++

C1

++

C1

C2

C5

C5

C7

C9

COVID-19 New Products, Anti-SARS-CoV-2 Fully Human RBD IgG Quality Controls

Figure 1: Colloidal Gold Colorimetric Card, the Higher the Number, the Lower the Activity, B Refers to Undetectable.



Product Information


1.      Antigens for Colloidal Gold Antibody Capture Method

Catalog No.

Epitope

Source

FPZ0515

N Protein

E. coli

FPZ0516

FPZ0517

FPZ0564

FPZ0533

S Protein(His)

FPZ0557

S Protein(mFC)

CHO

FPZ0537

S Protein(His)


2.   Antigens for Indirect Colloidal Gold Method

Catalog No.

Epitope

Source

Recommended Application

FPZ0515

N Protein

E. coli

Coating

FPZ0516

FPZ0517

FPZ0555

S Protein

CHO








3.   Antigens for Colloidal Gold Sandwich Method

Catalog No.

Source

Recommended Application

FPZ0556

CHO

Coating

FPZ0533

E. coli

Conjugate


4.  Antigens for Indirect ELISA Method

Catalog No.

Epitope

Source

Recommended Application

FPZ0512

N Protein

E. coli

Coating

FPZ0513

FPZ0514

FPZ0537

S Protein

CHO

FPZ0555


Welcome to email market@fapon.com for more information!


  form>